View More Recent Stories

Oct 3, 2024 03:10PM Praxis Precision Medicines (PRAX) spreader active in November 65 and 90 calls as share price up 9.6%
Oct 3, 2024 06:09AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 24, 2024 08:39AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 10, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025
Sep 4, 2024 07:36AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 4, 2024 07:12AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $151 at Needham
Sep 3, 2024 04:10PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $143 at Oppenheimer
Sep 3, 2024 02:56PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 01:57PM Guggenheim Defending Praxis Precision Medicines Inc. (PRAX): 'we are buyers, especially on the current weakness'
Sep 3, 2024 10:20AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 07:50AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 07:31AM Praxis Precision Medicines (PRAX) announces positive topline results from the EMBOLD study in SCN2A and 8A developmental epilepsies, highlighting the disease-modifying potential of relutrigine
Aug 21, 2024 07:42AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 14, 2024 06:42AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $120 at H.C. Wainwright
Aug 13, 2024 04:44PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $170 at Guggenheim
Aug 5, 2024 06:01AM Oppenheimer Starts Praxis Precision Medicines Inc. (PRAX) at Outperform
Jul 18, 2024 07:50AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Jul 1, 2024 07:19AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Jun 17, 2024 07:53AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
View More Recent Stories